Notes • Does not have any family relationships with any directors and/or any major shareholders of the Company • Does not have any conflict of interest with the Company • Does not have any convictions for offences within the past five years other than for traffic offences, if any Work Experience Dr Kenneth Tsang was appointed as Regional Chief Executive Officer, IHH Healthcare North Asia, effective from 1 April 2024. In conjunction with his role as Chief Executive Officer of Gleneagles Hospital Hong Kong, he provides oversight for Gleneagles Hospital, Gleneagles Healthcare ambulatory care centres and primary clinics, and Parkway Laboratory Services in Hong Kong. His strategic leadership, including his position as Chairman of IHH China Operations Steering Committee, plays a pivotal role in advancing our operations in China towards sustainable long-term growth. Dr Tsang joined Gleneagles Hospital Hong Kong in 2019 as Chief Operating Officer before rising to become its Chief Executive Officer in 2021. Prior to IHH, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician in Queen Elizabeth Hospital before becoming a full-time medical administrator at its Head Office, taking up management roles in patient safety, strategy and service planning, infection control and cluster services. Dr Tsang is a Fellow of the Hong Kong Academy of Medicine (Community Medicine), a Fellow of the Hong Kong College of Community Medicine and a Fellow of The Royal Australasian College of Medical Administrators. He is also an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine of The University of Hong Kong. Academic/Professional Qualification(s) • Bachelor of Medicine & Surgery, The University of Hong Kong • Master of Occupational Medicine, The Chinese University of Hong Kong Dr Kenneth Tsang Regional Chief Executive Officer, IHH Healthcare North Asia Nationality: Chinese Gender: Male Age: 54 (As at 5 April 2024) Date of Appointment: 1 April 2024 Work Experience Dr Zhiping Li is responsible for the strategic business planning and management of IHH’s operations and facilities in China. Apart from hospital and clinic operations, he also oversees the corporate, governance and control functions of the China corporate office. A healthcare veteran with over 30 years of experience in the United States and Chinese healthcare industry, Dr Li has assumed diverse roles and risen through the ranks across his career. His past employers include the University of North Carolina at Chapel Hill, North Carolina, John Hopkins Medicine in Baltimore, Maryland, and most recently Taikang Xianlin Drum Tower Hospital in Nanjing, China, where he served as President. Academic/Professional Qualification(s) • Bachelor of Medicine & Surgery, Shanghai Second Medical University, China • Residency, Case Western Reserve University, Cleveland, Ohio, USA • Fellowship, Johns Hopkins Medicine, Baltimore, Maryland, USA Dr Zhiping Li Chief Executive Officer, IHH Healthcare China Nationality: American Gender: Male Age: 58 (As at 5 April 2024) Date of Appointment: 26 October 2020 Annual Report 2023 83
RkJQdWJsaXNoZXIy NDgzMzc=